DEEPCURE
DeepCure is an accelerated breakthrough in science, developed by world-leading AI engineers, data scientists, and biologists.
DEEPCURE
Industry:
Artificial Intelligence Biotechnology Product Research
Founded:
2018-01-01
Address:
Boston, Massachusetts, United States
Country:
United States
Website Url:
http://www.deepcure.ai
Total Employee:
11+
Status:
Active
Email Addresses:
[email protected]
Total Funding:
40 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible Google Analytics Apple Mobile Web Clips Icon Google Tag Manager WordPress Google Universal Analytics Font Awesome Global Site Tag Nginx
Similar Organizations
AccutarBio
AccutarBio employs artificial intelligence to revolutionize drug discovery.
Qureator (Formerly known as Curiochips)
Precision Architecture For Drug Discovery
Dyno Therapeutics
Dyno Therapeutics is a biotechnology company that uses artificial intelligence for gene therapy.
HelixNano
Helix Nanotechnologies uses artificial intelligence to help cure genetic diseases.
KSQ Therapeutics
KSQ Therapeutics is using CRISPR technology within a powerful drug discovery engine to enable high-confidence drug development.
PostEra
PostEra is building a modern 21st century biopharma. We're using our advances in machine learning to bring more cures to patients
Proscia
Proscia develops a pathology platform to assist routine pathology operations, enhance cancer diagnosis, and improve patient outcomes.
Protai
Protai is an AI-powered drug discovery startup.
Scailyte
True precision medicine through single-cell science
Current Advisors List
Current Employees Featured
Founder
Investors List
Sapir Venture Partners
Sapir Venture Partners investment in Series A - DeepCure
Benon Group Ltd.
Benon Group Ltd. investment in Series A - DeepCure
TLV Partners
TLV Partners investment in Series A - DeepCure
Morningside Venture Investments
Morningside Venture Investments investment in Series A - DeepCure
The E14 Fund
The E14 Fund investment in Seed Round - DeepCure
Sapir Venture Partners
Sapir Venture Partners investment in Pre Seed Round - DeepCure
Creative Destruction Lab (CDL)
Creative Destruction Lab (CDL) investment in Pre Seed Round - DeepCure
Key Employee Changes
| Date | New article |
|---|---|
| 2022-04-26 | DeepCure Appoints Dr. Han Lim as Chief Business Officer |
Official Site Inspections
http://www.deepcure.ai Semrush global rank: 9.74 M Semrush visits lastest month: 114
- Host name: 198.49.23.144
- IP address: 198.49.23.144
- Location: New York United States
- Latitude: 40.7157
- Longitude: -74
- Metro Code: 501
- Timezone: America/New_York
- Postal: 10013
More informations about "DeepCure"
DeepCure
DeepCure is a Boston-based therapeutics company that harnesses advanced AI, physics-based tools and automation to discover novel small molecules for challenging targets. DeepCure currently has a lead asset in IND-enabling โฆSee details»
DeepCure - Crunchbase Company Profile & Funding
DeepCure builds an AI engine for small-molecule drug discovery. The company is utilizing AI-driven drug discovery to expedite the advancement of โฆSee details»
DeepCure - LinkedIn
DeepCure discovers transformative small molecule therapies for immune and inflammatory diseases. The company uses a chemistry platform that combines AI, physics-based tools and automated chemical ...See details»
DeepCure - Funding, Financials, Valuation & Investors - Crunchbase
DeepCure leverages AI and AI-enabled technologies to advance small molecule discovery techniques. New. Resources. Advanced Search. Start Free Trial . Talk With Sales. ... How โฆSee details»
DeepCure Inc. | STEX - Startup
DeepCure's AI helps identify novel optimization steps that would escape the eyes of even the most experienced medicinal chemist. These steps improve the success rates of drug โฆSee details»
In The News โ DeepCure
DeepCure, a therapeutics company using AI to discover novel drugs for inflammation and immune diseases, today announced it will present early safety and efficacy data for their BRD4 (BD2) โฆSee details»
DeepCure Inc. Company Profile | Boston, MA - Dun & Bradstreet
Find company research, competitor information, contact details & financial data for DeepCure Inc. of Boston, MA. Get the latest business insights from Dun & Bradstreet.See details»
Home - DeepCure
The organization offers a range of key services aimed at streamlining hospital operations to optimize their revenue. Our Resolved Cases. See the Real Results of the Cases We Have โฆSee details»
DeepCure | StartupHub.ai
Sep 1, 2018 DeepCure is an AI-driven drug discovery startup founded in 2018. Their AI algorithms analyze a trillion drug candidates to identify the most promising ones while โฆSee details»
Israeli Startup DeepCure Is Developing Medications โฆ
Apr 15, 2024 DeepCure is an Israeli medtech startup that uses an artificial intelligence AI drug discovery engine to develop novel, small molecule therapeutics. The company closed a $24.6 million Series A-1 ...See details»
DeepCure, Inc. (DeepCure, Inc.) - ่ฏ็ฉ็ฎก็บฟ_ไธๅฉ_ไธดๅบ่ฏ้ช_ๆ่่ฅ โฆ
About DeepCure DeepCure was founded by researchers at MIT to accelerate breakthrough therapies using artificial intelligence (AI) and AI-enabling technologies to innovate small โฆSee details»
AI in Drug Design: From Hype to Real-World Results โ DeepCure
Oct 11, 2024 So, is AI washing adversely impacting the field of drug design? Less than one might suppose, suggests Kfir Schreiber, co-founder and CEO of DeepCure. He points out that โฆSee details»
DeepCure's Automated Synthesis Transforms AI Drug Designs โฆ
May 30, 2024 Headquartered in Boston, DeepCure was founded in 2018 by scientists from the Massachusetts Institute of Technology to develop an AI platform that could identify new drugs โฆSee details»
DeepCure Unveils STAT6 Inhibitor Program with Novel Oral Small ...
Dec 19, 2024 DeepCure was founded by researchers at MIT to accelerate breakthrough therapies using artificial intelligence (AI) and AI-enabling technologies to innovate small โฆSee details»
DeepCure Turns Complex Drug Designs into Testable Molecules โฆ
BOSTON, May 28, 2024--DeepCure, a leader in discovering novel therapeutics powered by AI and automation, announced today that its Inspired Chemistryโข platform had achieved a โฆSee details»
DeepCure Inc., Greece - Life-Sciences-Europe.com
Nov 8, 2021 Deepcure was founded to accelerate breakthrough science, developed by world-leading AI engineers, data scientists, and biologists. Using an end-to-end drug discovery โฆSee details»
DeepCure's AI platform creates novel Brd4 inhibitor
Sep 9, 2024 Boston-based DeepCure may be an AI-focused biotech, but it sets itself apart by focusing its AI-powered platform on historically challenging drug targets that have eluded โฆSee details»
IAG Capital Partners Leads $24M in Generative AI Startup for Drug ...
Apr 11, 2024 DeepCure previously closed a $40 million Series A in 2021, led by Morningside Ventures, with participation TLV Partners, Sapir Venture Partners, and Benon Group. The โฆSee details»
DeepCure
The company uses a chemistry platform that combines AI, physics-based tools and automated chemical synthesis to identify truly novel molecules that address unsolved challenges. โฆSee details»
DeepCure Turns Complex Drug Designs into Testable Molecules โฆ
May 28, 2024 BOSTON--(BUSINESS WIRE)-- DeepCure, a leader in discovering novel therapeutics powered by AI and automation, announced today that its Inspired Chemistryโข โฆSee details»